A Marek's disease virus vIL-8 deletion mutant has attenuated virulence and confers protection against challenge with a very virulent plus strain

Avian Diseases

Volumn 49, Issue 2, 2005, Pages 199-206

  Cui, Xiaoping ^a,b   Lee, Lucy F ^a   Hunt, Henry D ^a   Reed, Willie M ^b   Lupiani, Bianca ^c   Reddy, Sanjay M ^a,c  

^a U S DEPARTMENT OF AGRICULTURE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Marek's disease virus (MDV); Protection efficiency; Recombinant virus; Tumor incidence; vIL 8; Virulence

Indexed keywords

AVES; GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPES; HERPESVIRIDAE;

EID: 19544380702     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/7277-091004     Document Type: Article

References (26)

1. Agresti, A. A survey of exact inference for contingency tables. Stat. Sci. 7:131-153. 1992.
2. Buckmaster, A. E., S. D. Scott, M. J. Sanderson, M. E. Boursnell, N. L. Ross, and M. M. Binns. Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: implications for herpesvirus classification. J. Gen. Virol. 69:2033-2042. 1988.
3. Billow, V., and P. M. Biggs. Differentiation between strains of Marek's disease. Avian Pathol. 6:395-403. 1975.
4. Calnek, B. W., and R. L. Witter. Marek's disease. In: Diseases of poultry. B. W. Calneck, H. J. Barnes, C. W. Beard, L. R. McDougald, and Y. M. Saif, eds. Iowa State University Press, Ames, IA. pp. 369-413. 1997.
5. Churchill, A. E., and P. M. Biggs. Agent of Marek's disease in tissue culture. Nature 215:528-530. 1967.
6. Churchill, A. E., and P. M. Biggs. Herpes-type virus isolated in cell culture from tumors of chickens with Marek's disease. II. Studies in vivo. J. Natl. Cancer Inst. 41:951-956. 1968.
7. Cortes, P. L., and C. J. Cardona. Pathogenesis of a Marek's disease virus mutant lacking vIL-8 in resistant and susceptible chickens. Avian Dis. 48:50-60. 2004.
8. Cui X., L. F. Lee, W. M. Reed, H. J. Kung, and S. M. Reddy. Marek's disease virus encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency. J. Virol. 78:4753-4760. 2004.
9. Cui, Z. Z., D. Yan, and L. F. Lee. Marek's disease virus gene clones encoding virus-specific phosphorylated polypeptides and serological characterization of fusion proteins. Virus Genes 3:309-322. 1990.
10. Lee, L. F., P. Wu, D. Sui, D. Ren, J. Kamil, H. J. Kung, and R. L. Witter. The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus. Proc. Natl. Acad. Sci. USA 97:6091-6096. 2000.
11. Liu, J. L., S. F. Lin, L. Xia, P. Brunovski, D. Li, I. Davidson, L. F. Lee, and H. J. Kung. MEQ and V-IL8: cellular genes in disguise? Acta Virol. 43:94-101. 1999.
12. Lupiani, B., L. F. Lee, X. Cui, I. Gimeno, A. Anderson, R. W. Morgan, R. F. Silva, R. L. Witter, H. J. Kung, and S. M. Reddy. Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc. Natl. Acad. Sci. USA 101:11815-11820. 2004.
13. Martins-Green, M. The chicken Chemotactic and Angiogenic Factor (cCAF), a CXC chemokine. Int. J. Biochem. Cell Biol. 33:427-432. 2001.
14. McGeoch, D. The genomes of the human herpesviruses: contents, relationships, and evolution. Annu. Rev. Microbiol. 43:235-265. 1989.
15. Parcells, M. S., S. F. Lin, R. L. Dienglewicz, V. Majerciak, D. R. Robinson, H. C. Chen, Z. Wu, G. R. Dubyak, P. Brunovskis, H. D. Hunt, L. F. Lee, and H. J. Kung. Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J. Virol. 75:5159-5173. 2001.
16. Payne, L. N., J. A. Frazier, and P. C. Powell. Pathogenesis of Marek's disease. Int. Rev. Exp. Pathol. 16:59-154. 1976.
17. Payne, L. N., and M. Rennie. B and T lymphocyte responses in Marek's disease. Bibl. Haematol. 43:351-353. 1975.
18. Reddy, S. M., B. Lupiani, I. M. Gimeno, R. F. Silva, L. F. Lee, and R. L. Witter. Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc. Natl. Acad. Sci. USA 99:7054-7059. 2002.
19. Schat, K. A., and Z. Xing. Specific and nonspecific immune responses to Marek's disease virus. Dev. Comp. Immunol. 24:201-221. 2000.
20. Strieter, R. M., S. L. Kunkel, V. M. Elner, C. L. Martonyi, A. E. Koch, P. J. Polverini, and S. G. Elner. Interleukin-8. A corneal factor that induces neovascularization. Am. J. Pathol. 141:1279-1284. 1992.
21. Witter, R. L. Attenuated revertant serotype 1 Marek's disease viruses: safety and protective efficacy. Avian Dis. 35:877-891. 1991.
22. Witter, R. L. Increased virulence of Marek's disease virus field isolates. Avian Dis. 41:149-163. 1997.
23. Witter, R. L. Protective efficacy of Marek's disease vaccines. Curr. Topics Microbiol. Immunol. 255:57-90. 2001.
24. Witter, R. L. Induction of strong protection by vaccination with partially attenuated serotype 1 Marek's disease viruses. Avian Dis. 46:925-937. 2002.
25. Witter, R. L., G. H. Burgoyne, and J. J. Solomon. Evidence for a herpesvirus as an etiologic agent of Marek's disease. Avian Dis. 13:171-184. 1969.
26. Witter, R. L., L. F. Lee, and A. M. Fadly. Characteristics of CVI988/ Rispens and R2/23, two prototype vaccine strains of serotype 1 Marek's disease virus. Avian Dis. 39:269-284. 1995.